Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2.92

Margin Of Safety %

-3

Put/Call OI Ratio

0.91

EPS Next Q Diff

0.25

EPS Last/This Y

0.56

EPS This/Next Y

0.49

Price

86.64

Target Price

100.29

Analyst Recom

1.48

Performance Q

11.34

Relative Volume

0.56

Beta

1.46

Ticker: DXCM




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08DXCM85.750.900.70135169
2025-05-09DXCM84.660.890.54136254
2025-05-12DXCM85.010.891.20132114
2025-05-13DXCM83.940.900.45133794
2025-05-14DXCM86.510.880.20136213
2025-05-15DXCM85.580.871.20137640
2025-05-16DXCM85.470.870.88138621
2025-05-19DXCM86.990.860.42127989
2025-05-20DXCM87.340.860.73128574
2025-05-21DXCM84.980.860.88129066
2025-05-22DXCM84.780.860.42129694
2025-05-23DXCM84.540.860.28130048
2025-05-27DXCM85.330.850.81129335
2025-05-28DXCM870.850.40133406
2025-05-29DXCM84.870.851.08134696
2025-05-30DXCM85.770.850.40135866
2025-06-02DXCM85.540.860.97133518
2025-06-03DXCM86.870.860.21135275
2025-06-04DXCM85.610.853.05135997
2025-06-05DXCM85.750.8624.45136607
2025-06-06DXCM86.650.912.67140815
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08DXCM85.324.273.92.02
2025-05-09DXCM84.664.248.42.02
2025-05-12DXCM85.054.258.52.02
2025-05-13DXCM84.114.245.92.02
2025-05-14DXCM86.474.277.52.02
2025-05-15DXCM85.634.246.52.02
2025-05-16DXCM85.484.253.02.02
2025-05-19DXCM86.964.268.82.02
2025-05-20DXCM87.344.258.42.02
2025-05-21DXCM84.924.232.42.02
2025-05-22DXCM84.834.254.32.02
2025-05-23DXCM84.544.452.02.02
2025-05-27DXCM85.333.562.72.02
2025-05-28DXCM87.003.570.62.02
2025-05-29DXCM84.853.535.02.02
2025-05-30DXCM85.803.563.82.02
2025-06-02DXCM85.533.652.32.02
2025-06-03DXCM86.793.666.92.02
2025-06-04DXCM85.653.644.22.02
2025-06-05DXCM85.743.656.12.02
2025-06-06DXCM86.643.663.32.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08DXCM-2.52-4.302.75
2025-05-09DXCM-2.52-4.302.75
2025-05-12DXCM-2.52-1.232.95
2025-05-13DXCM-2.52-1.232.95
2025-05-14DXCM-2.52-1.232.95
2025-05-15DXCM-2.52-1.232.95
2025-05-16DXCM-2.49-1.232.95
2025-05-19DXCM-2.434.112.95
2025-05-20DXCM-2.404.112.95
2025-05-21DXCM-2.404.112.95
2025-05-22DXCM-2.404.112.95
2025-05-23DXCM-2.324.112.95
2025-05-27DXCM-2.32-0.732.95
2025-05-28DXCM-2.32-0.732.92
2025-05-29DXCM-2.60-0.732.92
2025-05-30DXCM-2.60-0.732.92
2025-06-02DXCM-2.601.412.92
2025-06-03DXCM-2.581.412.92
2025-06-04DXCM-2.581.412.92
2025-06-05DXCM-2.581.412.92
2025-06-06DXCM-2.581.412.92
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.32

Avg. EPS Est. Current Quarter

0.45

Avg. EPS Est. Next Quarter

0.57

Insider Transactions

-2.58

Institutional Transactions

1.41

Beta

1.46

Average Sales Estimate Current Quarter

1125

Average Sales Estimate Next Quarter

1168

Fair Value

84.26

Quality Score

90

Growth Score

98

Sentiment Score

54

Actual DrawDown %

47.5

Max Drawdown 5-Year %

-63.3

Target Price

100.29

P/E

65.06

Forward P/E

34.13

PEG

2.73

P/S

8.19

P/B

14.99

P/Free Cash Flow

59.08

EPS

1.33

Average EPS Est. Cur. Y​

2.02

EPS Next Y. (Est.)

2.52

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.9

Relative Volume

0.56

Return on Equity vs Sector %

-0.4

Return on Equity vs Industry %

5.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

63.3
DexCom, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 10200
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
stock quote shares DXCM – DexCom, Inc. Stock Price stock today
news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DXCM – DexCom, Inc. yahoo finance google finance
stock history DXCM – DexCom, Inc. invest stock market
stock prices DXCM premarket after hours
ticker DXCM fair value insiders trading